AI’s disease promise meets the limits of the clock
- Dario Amodei says AI could make several major diseases relics within a decade.
- Some hosts see a path through faster biological research; others warn the forecast could give patients false hope.
Anthropic CEO Dario Amodei says cancer, Alzheimer’s, heart disease and mental illness could become relics within a decade. The forecast has prompted a debate over whether AI is accelerating medical discovery fast enough to make that timeline credible, and what patients might hear in such a sweeping promise.
On Breaking Points, Ryan and Emily treated the prediction as an aggressive pitch. On This Week in Startups, DA Wallach warned that sweeping timelines can give patients false hope. Wallach put the chance of curing all diseases within that period at 1% to 5%; Ben Lerer put it below 1%. Those estimates concern curing all diseases, a broader claim than Amodei’s forecast about four major conditions.
There is a more incremental possibility. On Moonshots, Immad Akhund estimated AI could help identify core disease mechanisms in two to three years, while translating discoveries into cures could take five to ten. The hosts pointed to virtual cells and faster trials as ways research might move more quickly, not as proof that cures are imminent.
David Friedberg, on All-In, said AI-assisted biological discovery is already producing real breakthroughs, while cautioning that the timeline remains uncertain. The debate, then, is not simply whether AI can help science: it is whether progress in finding mechanisms can turn into treatments quickly enough to meet Amodei’s decade-long forecast.
Source Intelligence
- Deep dive into what was said in the episodes
Jensen Ousted as Nvidia CEO: "Spy" Scandal, Export Restrictions, Market Impact • Nov 14
- Anthropic CEO Dario Amodei said cancer, Alzheimer's, heart disease, and mental illness could become relics within a decade; David Friedberg says AI-enabled biological discovery is already producing real breakthroughs, though the timeline remains uncertain.
Also discussed on this episode: (16)
Chips (4)
- The host says Jensen Huang left Nvidia after a six-day crisis: the stock fell 15% in a week, the board began seeking a CEO, and the CFO became interim CEO ahead of earnings.
- David Friedberg describes Jensen as central to Nvidia's long chip-development cycle: the company struggled for years, then its stock rose roughly 20-fold in four years and it reported $63 billion in operating profit.
- David Sacks says Nvidia's advantage comes from rapid chip iteration, not a single generation; he warns that disruption could give Huawei time to close the gap, while other chipmakers still face manufacturing and scale-up constraints.
- Jason Calacanis favors shareholder input on Jensen's removal and says Nvidia needs a risk-taking wartime CEO; proposed successors included internal candidate Ian Buck and external candidates Renee Haas and Nikesh Arora.
China (4)
- The New York Times reported that Alice Wang, a Megaspeed executive with ties to Jensen Huang, was a Chinese spy and helped route Nvidia chips to Chinese firms; David Sacks stresses that the allegations and any smuggling remain unproven.
- David Sacks calls for separate investigations into possible chip smuggling and the leak of classified intelligence, asking who leaked it, why Jensen received no defensive briefing, what secrets he supposedly possessed, and whether Alice Wang was a spy.
- David Sacks contrasts Jensen's case with Eric Swalwell's relationship with suspected Chinese spy Fang Fang, after which Swalwell received a defensive briefing and remained in Congress and on the House Intelligence Committee.
- David Sacks says Biden restricted leading-edge chips to China while allowing unlimited, unlicensed sales of lagging chips; the Trump administration kept the distinction but required licenses and limited quantities, and China has blocked Nvidia products to support Huawei.
Enterprise (2)
- David Friedberg and Chamath Palihapitiya say the board's immediate concern may have been Jensen's company-code disclosures and executive attestations, with potential consequences for director-and-officer insurance and board liability.
- Jason Calacanis says Anthropic is bundling workplace software into Claude, including legal, finance, spreadsheets, whiteboards, meetings, and video calls; he argues the subscription bundle could displace SaaS products by reducing interoperability friction.
Open Source (1)
- David Friedberg argues that Jensen favored broad access to AI and open-source development, while government control of chips, telemetry, and kill switches could centralize power; Chamath warns Nvidia's investment role may slow with Jensen gone.
Regulation (1)
- David Sacks says bipartisan pressure could turn chip tracking into a government-controlled system; he also accuses Democratic opponents of data centers of overlooking China-linked political activity against proposed projects.
Markets (1)
- Chamath says Nvidia's value loss creates major civil-claim exposure, while David Sacks calls for a Justice Department investigation of the classified leak and insists Jensen is innocent unless proven guilty.
Startups (1)
- Anthropic's reported IPO plan priced 825 million shares at $70 to $78, implying a $1.4 trillion valuation and a $90 billion raise; seven founders planned individual sales while pledging most of their remaining holdings to charity.
Safety (1)
- David Sacks argues Anthropic is racing toward recursive self-improvement and a winner-take-all market, creating safety risks while concentrating AI power; he says safety groups should scrutinize that direction rather than celebrate Jensen's removal.
Macro (1)
- Chamath Palihapitiya predicted a recession by 2028, while David Friedberg said Anthropic is the best provider for much of his group's biology work and that his team also built an open-source system on its own racks.
Jensen’s Departure, NVIDIA’s succession plan, AI doomer response, and Demis talks RSI | MOONSHOTS #311 (recorded live) • Nov 14
- Dario Amodei said cancer, Alzheimer’s, heart disease, and mental illness could become relics within a decade. Immad Akhund estimated that AI could identify core disease mechanisms in two to three years, but said translating discoveries into cures could take five to ten years; the hosts emphasized virtual cells and faster trials.
Also discussed on this episode: (14)
Big Tech (1)
- Peter Diamandis said an Outlook outage disrupted his work and cited 100,000 to 130,000 reported user problems. The hosts linked communication failures to cyber risk from agent swarms attacking exposed systems.
Space (2)
- Peter Diamandis said Starship Flight 15 was scheduled for Friday the 13th, with a booster catch and a Starship catch 22 hours later. He speculated that launches could eventually reach 1,000 or even 10,000 per year.
- A researcher used Claude to search Vera Rubin Observatory data and identify a candidate dwarf planet, estimated at 590 kilometers wide and roughly twice Pluto’s distance from the Sun. The hosts argued that AI can uncover discoveries already present in archives but missed by human analysis.
Chips (2)
- Peter Diamandis presented Jensen Huang’s resignation as potentially connected to reported affairs and alleged chip diversion through Singapore to China; Alex Wissner-Gross argued that U.S. officials may have pushed the story to support export controls. Speakers stressed that the allegations were unproven.
- NVIDIA named CFO Colette Kress interim CEO and Harvey Jones board chair. The hosts said a successor must preserve CUDA and TSMC relationships, investor confidence, and NVIDIA’s role in financing AI companies; Alex Wissner-Gross warned that Jensen-style founder leadership may be hard to replace.
Safety (2)
- Paul Christiano warned of a high risk of AI takeover within three years, while acknowledging that no quantitative model supports a precise probability. Immad Akhund rejected the takeover framing, pointing instead to cyber and biological risks; Akhund said his own p(doom) had fallen from 50% to 20%.
- The hosts argued that AI labs should make alignment work concrete and public, with independent oversight and clearer definitions. They debated whether training data should encode shared values, warning that a U.S. national ideological test could resemble the Chinese Communist Party’s required ideological review of public models.
Models (1)
- Demis Hassabis warned that closed-loop recursive self-improvement without human review could accelerate AGI and produce systems difficult to understand or control. The hosts disagreed on how close labs are to that point, citing automated training, model swarms, and the difficulty of meaningful human oversight at scale.
Enterprise (1)
- Anthropic launched Claude Whiteboard and Sheets in beta, Claude Data generally, and Claude Meetings for Google Meet; it also added connectors for third-party apps. The hosts saw agents displacing software interfaces, while noting that Microsoft retains distribution, compliance, support, and enterprise permissions.
AI Infrastructure (1)
- Planet launched an AI app that lets users query a decade of satellite imagery across more than 3,000 layers. Separately, an agent search of public NASA lidar data flagged a possible Mayan site in Mexico; 48 agents screened 1,200 square kilometers, and officials called it an original finding.
History (1)
- A creator used Fable 5.2 to reconstruct ancient Babylon from historical documents and archaeological plans in eight hours. The hosts described such tools as early steps toward interactive historical worlds and large-scale computational archaeology using accumulated records and imagery.
Labor (1)
- Immad Akhund said UBI needs to arrive before job displacement and unrest, citing successful prior experiments but warning that some states block local trials. Peter Diamandis predicted federal payments of $3,000 a month if conditions deteriorate, while Alex Wissner-Gross argued AI could also help solve social and political problems.
VC (1)
- Immad Akhund said NVIDIA often invested 10% to 20% of AI funding rounds and sometimes committed billions to strategic companies; he expects that funding to retreat after Huang’s departure. He argued that investment may shift toward automated wet labs and robotics, while Anthropic’s IPO could add liquidity.
Reasoning (1)
- The hosts argued that AI may discover concepts humans cannot formulate or verify, while disagreeing over whether advanced models will be alien or increasingly humanlike. Alex Wissner-Gross cited brain-activation decoding research; Immad Akhund said AI could help solve economic and social transitions as well as scientific problems.
Founders Are Now Sending VCs a File Written for AI • Nov 12
- DA Wallach criticizes Dario Amodei's prediction that cancer, Alzheimer's, heart disease, and mental illness could become relics within a decade, arguing that sweeping timelines can give false hope to patients. Wallach puts the chance of curing all diseases within that period at 1% to 5%; Ben Lerer puts it below 1%.
Also discussed on this episode: (21)
VC (10)
- Jenny Fielding says Everywhere Ventures backs pre-seed founders with its first institutional check, typically $250,000 in rounds around $1 million, before traction is clear. The fund has invested in 300 companies across health and work.
- Ben Lerer and Jenny Fielding say early-stage investors often back teams before the business is settled; Fielding estimates at least a third of her portfolio, including some of its biggest companies, pivoted. Lerer expects AI to make software pivots more common as products and markets shift quickly.
- Jason Calacanis says small checks can fail the fund-return test: a $100,000 investment at a $20 million valuation could leave a fund with only 50 basis points of ownership, requiring an extraordinary company outcome after dilution. He uses that math to reject deals that cannot plausibly return the fund.
- Jenny Fielding and Ben Lerer argue that AI can handle more investment analysis while investors preserve time for founder relationships. Fielding values being a founder's first call on a bad day; Jason Calacanis describes the investor's human role as encouragement and judgment through a company's chaos.
- Jenny Fielding says Everywhere Ventures built Jelly to give venture investors affordable company and investor intelligence, including what investors discuss publicly. The beta drew 1,000 sign-ups after its announcement, and the team is considering a low monthly price against data products that can cost tens of thousands per seat.
- Jenny Fielding cites a shift among family offices from VC funds toward single-company SPVs: SPVs accounted for 34% of their VC commitments, up from 9% in 2019. Ben Lerer says OpenAI and Anthropic allocations inflate the trend, while investors also chase visible late-stage AI gains and co-investment access.
- Jenny Fielding says emerging-manager fundraising has contracted sharply, with fewer funds closing each year; she expects many managers to fail to raise. Ben Lerer describes a barbell market in which capital concentrates in mega-funds and the earliest stage, leaving mid-sized funds squeezed.
- Jason Calacanis says his firm charges a one-time 2% sourcing fee and 20% carry on SPVs, while some operators charge 2% to 3% annually. The panel warns that opaque fees, nested vehicles, and weak disclosure could lead to lawsuits when private-company outcomes disappoint.
- DA Wallach says investors should compare late-stage private-company SPVs with public-market peers, not early-stage funds, because their risk, valuation, and outcome ranges differ. Jenny Fielding warns that fund managers are increasingly asked to source allocations in companies they do not know well, shifting selection work onto LPs.
- Jason Calacanis says early investors need to enforce pro rata rights rather than surrender them in later rounds. He says his firm prevailed in 11 of 12 disputes, sometimes by telling a founder it would sell its shares rather than accept being cut out.
Biology (1)
- DA Wallach says biotech pivots become harder once a company commits to an indication because clinical trials carry steep fixed costs. Early teams can still test where a technology or molecule has the greatest impact before entering human trials.
Startups (5)
- Jason Calacanis says his best-returning investment in Micro One came after founder Ali shifted from ranking developers to selling data to a large language model company. Calacanis says the company reached $1 billion in revenue after his fund invested at a $12 million valuation.
- Ben Lerer says vibe-coded software can reach feature parity for niche users, but distribution, data advantages, security, and enterprise readiness still protect incumbents. Jenny Fielding sees room for narrow products built for communities that cannot afford or do not need generalized platforms.
- Ben Lerer says Kevin Rose built a Slack alternative by working four to five hours a day for about a month, illustrating how quickly people can now build useful software. Lerer also says venture firms have begun building companies in-house when a partner sees a market but no suitable founder.
- Ben Lerer says investors increasingly favor younger teams that can move quickly, use fleets of agents, and cover more ground as software moats shrink. Speed matters because competitors can now build similar products before a company establishes durable distribution or data advantages.
- Ben Lerer says Launchpoint lets brands buy user-generated-content advertising with targeting and scale similar to established ad platforms. He describes it as a new performance-marketing channel that can create paid work for a growing group of creators.
Agents (3)
- Hib Keshi's company.md pitch format lets investors query a company file with an LLM instead of relying only on decks or calls. Jenny Fielding says Everywhere Ventures redesigned its website for agent discovery after finding that 99% of reviewed VC sites lacked agent-friendly FAQs and pages.
- Ben Lerer says AI produces strong market maps and deal analysis but weak investment recommendations, often returning middling scores. His team scores founder expertise and responses to challenge, then checks whether ownership and fund math support a fund-returning outcome.
- Ben Lerer points to Black Letter as an AI-first law firm that charges for completed work rather than billable time. The model reframes legal pricing around a fixed, quality-assured result instead of the hours spent producing it.
Robotics (1)
- DA Wallach says Phantom Neuro's implant detects nerve signals beneath the skin and above the muscle, allowing an amputee to control a robotic limb by intention. The device is minimally invasive, can be implanted in under an hour, and entered its first patient study in Australia.
Safety (1)
- Jason Calacanis says Obliteration AI gives vetted cybersecurity teams access to models with safety guardrails removed so they can red-team systems before attackers exploit them. The company moved from Calacanis's accelerator to Speedrun, which he says reviews startups quickly and competes with Y Combinator.
11/11/26: Jim Jordan Picked For House Minority Leader, Anthropic Plots $1.4 Trillion IPO, Pod Save Panelist Claims Gaza Hurt Abdul • Nov 11
- Dario Amodei said cancer, Alzheimer’s, heart disease, and mental illness could become relics within a decade, and argued that managing AI risks would help earn public trust. Ryan and Emily treated the promise as an aggressive pitch for Anthropic’s IPO.
Also discussed on this episode: (15)
Elections (5)
- Jim Jordan defeated Steve Scalise for House Republican minority leader, a victory for the party’s populist wing. Jordan had defended a war with Iran in March, saying Americans could accept temporarily higher prices to stop Iran from obtaining a nuclear weapon.
- A War Room speaker argued that Jordan failed to act on FBI whistleblowers after Republicans won the House in 2022, and that Jordan had displaced Louie Gohmert from the Judiciary chairmanship. The speaker also said Jordan lost standing in the Freedom Caucus after repeatedly yielding to party leaders.
- Emily said AIPAC-affiliated individual donors had not previously ranked among Jordan’s top 20 campaign and leadership PAC donor groups, but did so this cycle. She flagged the shift as a developing story, while Ryan noted that Scalise was seen as more aligned with special interests and the establishment.
- Ryan said Trump’s 2016 nomination froze the Republican civil war because insurgents had to pledge loyalty to Trump to avoid primary challenges. With Trump’s grip weakening, he expects renewed challenges to Republicans who became establishment figures; Emily put the Freedom Caucus at roughly 30 to 40 members at its peak.
- At a Pod Save America event, Joel Rubin argued that only two Senate candidates who used the word “genocide” performed poorly and that Israel-Palestine did not help Democrats politically. Ryan challenged the comparison, citing differences in opponents and campaign spending; the audience pushed back on Rubin.
Big Tech (1)
- Emily said Jordan fought Google over alleged censorship but later resisted antitrust bills supported by Ken Buck and Mike Lee. A 2022 post by Will Chamberlain accused Jordan of using hearings to make consumers notice censorship while blocking measures that could curb Big Tech’s power.
AI Infrastructure (3)
- Anthropic’s filing put its prospective IPO valuation around $1.33 trillion, while the hosts described the target as roughly $1.4 trillion and said it was about $1 trillion below figures floated weeks earlier. The quoted share-price range was $70 to $78.
- Ryan criticized Anthropic’s IPO structure: its seven founders would retain control, while non-founder employees could sell 10% of their shares immediately, with 23 later opportunities for insiders to sell more. He said typical IPO lockups last at least six months and argued that the early exits shift downside risk to public investors.
- Ryan said Anthropic had raised hundreds of billions from private capital, had nearly exhausted private-credit funding, and faced close to $1 trillion in next-year compute and data-center liabilities against about $30 billion in revenue. Emily warned that losses and interconnected AI financing could make a company failure an economy-wide risk.
China (2)
- Emily and Ryan discussed allegations that NVIDIA CEO Jensen Huang had a relationship with Alice Wong, a former executive investigated as a possible Chinese intelligence asset. The Information reported that Wong’s company, Shanghai Century Litong, enabled at least $7.5 billion in NVIDIA chip sales to China since 2023; the hosts stressed that espionage claims remained unresolved.
- Ryan said a short-seller report had alleged NVIDIA was evading US restrictions on chip sales to China, and questioned why the FBI and NSA had not acted if the claims were publicly available. Emily said incompetence was the likeliest explanation, while raising a possible double-agent scenario as speculation.
Markets (1)
- NVIDIA had fallen 24% over the previous month and represented more than 6% of the S&P 500, according to the hosts. Jim Cramer called it the cheapest it had been in 10 years and a buy; Ryan and Emily said the company’s size and dependence on Jensen Huang made the market unusually exposed to a single firm.
Middle East (2)
- Ryan described Gaza’s fourth winter with displaced Palestinians living in tents, flooding, and damaged belongings. He said Israel continued restricting tents over claims that tent poles could have dual use, while the World Food Program and World Central Kitchen had sharply reduced food aid since October.
- Ryan said Gaza’s displaced population had been pushed into low-lying areas where winter flooding is predictable, while damaged sewage treatment left raw sewage and rats among the tents. He reported rising respiratory illness and heart conditions, and said reconstruction equipment promised under the ceasefire had not arrived.
Regulation (1)
- Emily corrected an earlier description of the Tim Scott-Elizabeth Warren housing bill: Trump refused to sign it because it lacked the SAVE Act, but the bill became law. She said the correction did not change her point that the bill had been stalled despite JD Vance campaigning on it.



